Trial Profile
Elucidation of individual difference factors in the pharmacokinetics and clinical effects of anticoagulants edoxaban and enoxasaparin
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 23 Mar 2021
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary) ; Enoxaparin sodium (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- 19 Mar 2021 Status changed from recruiting to discontinued.
- 03 Aug 2018 New trial record